Priv.-Doz. Dr. med. Wolfram Jabs

Facharzt für Innere Medizin und Nephrologie & Partnerarzt bei Fernarzt

Weitere Qualifikationen

  • Kaufeld J, Brinkkoetter PT, Schreiber A, Jabs WJ, Bieringer M, Bruck H, Menne J, Völker LA (2020) Caplacizumab: frequent local skin reactions. Annals of Hematology. https://doi.org/10.1007/s00277-020-04260-7
  • Völker LA, Kaufeld J, Miesbach W, Brähler S, Reinhardt M, Kühne L, Mühlfeld A, Schreiber A, Gaedeke J, Tölle M, Jabs WJ, Özcan F, Markau S, Girndt M, Bauer F, Westhoff TH, Felten H, Hausberg M, Brand M, Gerth J, Bieringer M, Bommer M, Zschiedrich S, Schneider J, Elitok S, Gawlik A, Gäckler A, Kribben A, Schwenger V, Schoenermarck U, Roeder M, Radermacher J, Bramstedt J, Morgner A, Herbst R, Harth A, Potthoff SA, von Auer C, Wendt R, Christ H, Brinkkoetter PT, Menne J (2020) ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP. Blood Advances 4: 3093–3101. https://doi.org/10.1182/bloodadvances.2020001987
  • Völker LA, Kaufeld J, Miesbach W, Brähler S, Reinhardt M, Kühne L, Mühlfeld A, Schreiber A, Gaedeke J, Tölle M, Jabs WJ, Özcan F, Markau S, Girndt M, Bauer F, Westhoff TH, Felten H, Hausberg M, Brand M, Gerth J, Bieringer M, Bommer M, Zschiedrich S, Schneider J, Elitok S, Gawlik A, Gäckler A, Kribben A, Schwenger V, Schoenermarck U, Roeder M, Radermacher J, Bramstedt J, Morgner A, Herbst R, Harth A, Potthoff SA, von Auer C, Wendt R, Christ H, Brinkkoetter PT, Menne J (2020) Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Advances 4: 3085–3092. https://doi.org/10.1182/bloodadvances.2020001973
  • Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, Jabs WJ, Özcan F, Wendt R, Hausberg M, Sellin L, Panzer U, Huber TB, Waldherr R, Hopfer H, Stahl RAK, Wiech T (2018) Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney International 94: 1177–1188. https://doi.org/10.1016/j.kint.2018.07.020
  • Paschke L, Lincke T, Mühlberg KS, Jabs WJ, Lindner TH, Paschke R (2018) Anti VEGF-TKI Treatment and New Renal Adverse Events Not Reported in Phase III Trials. European Thyroid Journal 7: 308–312. https://doi.org/10.1159/000491387
  • Brix SR, Noriega M, Herden EM, Goldmann B, Langbehn U, Busch M, Jabs WJ, Steinmetz OM, Panzer U, Huber TB, Stahl RAK, Wiech T (2018) Organisation of lymphocytic infiltrates in ANCA-associated glomerulonephritis. Histopathology 72: 1093–1101. https://doi.org/10.1111/his.13487
  • Meier M, Kramer J, Jabs WJ, Nolte C, Hofmann J, Krüger DH, Lehnert H, Nitschke M (2018) Proteinuria and the Clinical Course of Dobrava-Belgrade Hantavirus Infection. Nephron Extra 8: 1–10. https://doi.org/10.1159/000486322
  • Fagin U, Nerbas L, Vogl B, Jabs WJ (2017) Analysis of BZLF1 mRNA detection in saliva as a marker for active replication of Epstein-Barr virus. Journal of Virological Methods 244: 11–16. https://doi.org/10.1016/j.jviromet.2017.02.016
  • Brix SR, Stege G, Disteldorf E, Hoxha E, Krebs C, Krohn S, Otto B, Klätschke K, Herden E, Heymann F, Lira SA, Tacke F, Wolf G, Busch M, Jabs WJ, Özcan F, Keller F, Beige J, Wagner K, Helmchen U, Noriega M, Wiech T, Panzer U, Stahl RAK (2015) CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN. Journal of the American Society of Nephrology: JASN 26: 2105–2117. https://doi.org/10.1681/ASN.2014040407
  • Velden J, Paust H-J, Hoxha E, Turner J-E, Steinmetz OM, Wolf G, Jabs WJ, Özcan F, Beige J, Heering PJ, Schröder S, Kneißler U, Disteldorf E, Mittrücker H-W, Stahl RAK, Helmchen U, Panzer U (2012) Renal IL-17 expression in human ANCA-associated glomerulonephritis. American Journal of Physiology. Renal Physiology 302: F1663-1673. https://doi.org/10.1152/ajprenal.00683.2011
  • Vogl BA, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs WJ (2012) Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation. Journal of Medical Virology 84: 119–131. https://doi.org/10.1002/jmv.22258
  • Jabs WJ, Meier M, Lamprecht P, Steinhoff J, Nitschke M (2011) Local expression of C-reactive protein is associated with deteriorating graft function in acute and chronic failure of kidney transplants. Nephron. Clinical Practice 117: c390-397. https://doi.org/10.1159/000319871
  • Capraru D, Müller A, Csernok E, Gross WL, Holl-Ulrich K, Northfield J, Klenerman P, Herlyn K, Holle J, Gottschlich S, Voswinkel J, Spies T, Fagin U, Jabs WJ, Lamprecht P (2008) Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener’s granulomatosis. Clinical Immunology (Orlando, Fla.) 127: 144–150. https://doi.org/10.1016/j.clim.2007.12.004
  • Meier M, Nitschke M, Hocke C, Kramer J, Jabs W, Steinhoff J, Schutt M (2008) Insulin inhibits caspase-3 activity in human renal tubular epithelial cells via the PI3-kinase/Akt pathway. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 21: 279–286. https://doi.org/10.1159/000129386
  • Frenzel H, Pries R, Brocks CP, Jabs WJ, Wittkopf N, Wollenberg B (2007) Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein. Anticancer Research 27: 4111–4115.
  • Meier M, Nitschke M, Weidtmann B, Jabs WJ, Wong W, Suefke S, Steinhoff J, Fricke L (2006) Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. Transplantation 81: 1035–1040. https://doi.org/10.1097/01.tp.0000220480.84449.71
  • Jabs WJ, Busse M, Krüger S, Jocham D, Steinhoff J, Doehn C (2005) Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney International 68: 2103–2110. https://doi.org/10.1111/j.1523-1755.2005.00666.x
  • Jabs WJ, Maurmann S, Wagner H-J, Müller-Steinhardt M, Steinhoff J, Fricke L (2004) Time course and frequency of Epstein-Barr virus reactivation after kidney transplantation: linkage to renal allograft rejection. The Journal of Infectious Diseases 190: 1600–1604. https://doi.org/10.1086/424679
  • Maurmann S, Fricke L, Wagner H-J, Schlenke P, Hennig H, Steinhoff J, Jabs WJ (2003) Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers. Journal of Clinical Microbiology 41: 5419–5428. https://doi.org/10.1128/jcm.41.12.5419-5428.2003
  • Jabs WJ, Sedlmeyer A, Ramassar V, Hidalgo LG, Urmson J, Afrouzian M, Zhu L-F, Halloran PF (2003) Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. American Journal of Transplantation 3: 1501–1509. https://doi.org/10.1046/j.1600-6135.2003.00269.x
  • Jabs WJ, Theissing E, Nitschke M, Bechtel JFM, Duchrow M, Mohamed S, Jahrbeck B, Sievers H-H, Steinhoff J, Bartels C (2003) Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 108: 1428–1431. https://doi.org/10.1161/01.CIR.0000092184.43176.91
  • Jabs WJ, Lögering BA, Gerke P, Kreft B, Wolber E-M, Klinger MHF, Fricke L, Steinhoff J (2003) The kidney as a second site of human C-reactive protein formation in vivo. European Journal of Immunology 33: 152–161. https://doi.org/10.1002/immu.200390018
  • Wagner H-J, Fischer L, Jabs WJ, Holbe M, Pethig K, Bucsky P (2002) Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction. Transplantation 74: 656–664. https://doi.org/10.1097/00007890-200209150-00012
  • Jabs WJ, Wagner HJ, Maurmann S, Hennig H, Kreft B (2002) Inhibition of macrophage inflammatory protein-1 alpha production by Epstein-Barr virus. Blood 99: 1512–1516. https://doi.org/10.1182/blood.v99.5.1512
  • Seit 10/2016: Studium Master of Health Business Administration (MHBA), Friedrich-Alexander-Universität Erlangen-Nürnberg
  • Seit 08/2007: Leitender Oberarzt / stellvertretender Chefarzt, Klinik für Innere Medizin - Nephrologie, Vivantes Klinikum im Friedrichshain, Berlin
  • 2011 – 2019: Wissenschaftlicher Beirat Deutsche Gesellschaft für Innere Medizin
  • 07/2007: Habilitation für „Innere Medizin“ und Ernennung zum Privatdozenten, Universität zu Lübeck
  • 2006 – 07/2007: Oberarzt Abteilung Nephrologie und Interdisziplinäres Transplantationszentrum sowie Notaufnahme, Medizinische Klinik I, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
  • 2003 – 2007: Juniorprofessur „Transplantationsimmunologie“, Universität zu Lübeck
  • 2001 – 2007: Forschungslaborleiter „Experimentelle Nephrologie“, Universität zu Lübeck
  • 1999 – 2006: Assistenzarzt (Abteilungen für Nephrologie/Transplantation, Endokrinologie/Diabetologie, Rheumatologie, Kardiologie/Intensivmedizin, Gastroenterologie/Sonographie), Medizinische Klinik I, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
  • 1999 – 2003: Wissenschaftlicher Assistent, Medizinische Klinik I – Abteilung für Nephrologie, Universität zu Lübeck
  • 07/1999: Approbation als Arzt
  • 1998 – 1999: Arzt im Praktikum, Institut für Immunologie und Transfusionsmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
  • 1994 – 1998: Dissertation, Institut für Immunologie und Transfusionsmedizin, Universität zu Lübeck
  • 1993 – 1997: Studium Humanmedizin, Universität zu Lübeck
  • 1991 – 1993: Studium Humanmedizin, Philipps-Universität Marburg
  • 1989: Abitur in Osnabrück, Niedersachsen
  • 19.06.1970: geboren in Georgsmarienhütte, Niedersachsen